Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

219
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
219
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

5.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.1K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.4K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.4K
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

1.2K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.2K
Adrenergic Agonists: Indirect-Acting Agents01:25

Adrenergic Agonists: Indirect-Acting Agents

1.8K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.8K
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

510
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
510

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Factors Influencing Healthcare Providers' Referral Decisions to Cardiac Rehabilitation Programs in Riyadh City: A Cross-Sectional Study.

Journal of patient experience·2026
Same author

Clinical implications and pharmacological considerations of glycemic variability in patients with type 2 diabetes mellitus.

Scientific reports·2024
Same author

Trends of Over-the-Counter and Prescribed Medication Use During Pregnancy: A Cross-Sectional Study.

Journal of multidisciplinary healthcare·2023
Same author

Effect of low dose allopurinol on glycemic control and glycemic variability in patients with type 2 diabetes mellitus: A cross-sectional study.

Heliyon·2022
Same author

Clinical, Echocardiographic, and Therapeutic Characteristics of Heart Failure in Patients with Preserved, Mid-Range, and Reduced Ejection Fraction: Future Directions.

International journal of general medicine·2021
Same author

Predictors of Mortality in Patients with Chronic Heart Failure: Is Hyponatremia a Useful Clinical Biomarker?

International journal of general medicine·2020
Same journal

Precision Proteomic Profiling of Systemic Lupus Erythematosus-Correlating Disease Activity and Complement Levels with Clinical Phenotypes.

Biomedicines·2026
Same journal

The Role of Salivary Microbiota in Pancreatic Cancer: From Screening to Tumor Progression and Treatment Response.

Biomedicines·2026
Same journal

Diagnostic Utility of Surface Electromyography for Identifying Muscles Affected by Myofascial Trigger Points: A Scoping Review.

Biomedicines·2026
Same journal

Performance Assessment of a Locally Semi-Automated NGS-Based Workflow for Homologous Recombination Deficiency Testing in High-Grade Serous Ovarian Carcinoma.

Biomedicines·2026
Same journal

Coupling and Uncoupling Pleiotropy Between Hypertension and Type 2 Diabetes Contribute to Exploring Potential Heterogeneity in Cardiovascular Risk in East Asian Population.

Biomedicines·2026
Same journal

Maternal Response to Therapeutic Plasma Exchange in Early Gestation: A Case Series of Thrombotic Microangiopathies and Neurological Disorders.

Biomedicines·2026
See all related articles

Related Experiment Video

Updated: Aug 13, 2025

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K

Erectile Dysfunction: Pharmacological Pathways with Understudied Potentials.

Doaa R Adam1, Manal M Alem2

  • 1Department of Pharmaceutical Sciences, College of Pharmacy, Alfaisal University, P.O. Box 50927, Riyadh 11533, Saudi Arabia.

Biomedicines
|January 21, 2023
PubMed
Summary
This summary is machine-generated.

Erectile dysfunction (ED), a growing public health issue, is linked to cardiovascular risks and endothelial dysfunction. This review explores alternative pharmacological agents beyond PDE5 inhibitors for ED treatment.

Keywords:
atherosclerosisautonomic dysfunctionendothelial dysfunctionerectile dysfunctionnitric oxideoxidative stress

More Related Videos

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.6K
Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat
07:43

Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat

Published on: April 23, 2018

12.7K

Related Experiment Videos

Last Updated: Aug 13, 2025

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents
08:03

Intracavernosal Pressure Recording to Evaluate Erectile Function in Rodents

Published on: June 6, 2018

14.4K
Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model
05:48

Intracavernous Pressure Recording in a Cavernous Nerve Injury Rat Model

Published on: September 20, 2021

1.6K
Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat
07:43

Cavernous Nerve Stimulation and Recording of Intracavernous Pressure in a Rat

Published on: April 23, 2018

12.7K

Area of Science:

  • Urology
  • Cardiology
  • Pharmacology

Background:

  • Erectile dysfunction (ED) is a significant global health concern, increasingly affecting younger populations.
  • Epidemiological studies link ED to endothelial dysfunction and cardiovascular (CV) risk factors.
  • ED is now recognized as a clinical marker for future adverse CV events, impacting quality of life.

Purpose of the Study:

  • To review pharmacological agents investigated for erectile dysfunction (ED) beyond first-line phosphodiesterase type 5 (PDE5) inhibitors.
  • To present findings on agents with potential efficacy from limited human or experimental studies.
  • To guide future research into novel ED therapeutic pathways.

Main Methods:

  • Literature review of studies on pharmacological agents for ED.
  • Analysis of research focusing on non-PDE5 inhibitor treatments.
  • Inclusion of findings from both human subjects and experimental models.

Main Results:

  • Limited studies indicate favorable effects of certain pharmacological agents on ED.
  • Several alternative pathways and agents warrant further investigation.
  • Phosphodiesterase type 5 (PDE5) inhibitors remain the primary pharmacological treatment.

Conclusions:

  • ED is a critical indicator of underlying cardiovascular health.
  • Further research into underinvestigated pharmacological agents is crucial for advancing ED treatment.
  • Exploring novel therapeutic avenues beyond PDE5 inhibitors may improve patient outcomes.